Allogene Therapeutics Inc... (ALLO)
NASDAQ: ALLO
· Real-Time Price · USD
1.10
0.03 (2.80%)
At close: Aug 15, 2025, 3:59 PM
1.12
1.36%
After-hours: Aug 15, 2025, 07:51 PM EDT
Allogene Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -1.21 | -1.32 | -1.87 | -2.21 | -1.67 | -2.85 | -1.51 | -2.13 | -2.3 | -1.79 | -2.39 | -4.67 | -5.46 | -4.03 | -6.93 | -11.26 | -12.39 | -35.33 |
PEG Ratio | 0.07 | n/a | 0.15 | 0.26 | 0.21 | 0.11 | -0.04 | 0.07 | 0.11 | -0.59 | -0.17 | -0.4 | 0.76 | -1.09 | 1.32 | -1.49 | -0.11 | 0.67 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | 33.67K | -12.28K | 24.16K | 33.16K | 23.8K | 19.29K | 31.66K | 19.01K | 21.11K | 40.72K | 71.87K | 79.92K | 121.67 |
PB Ratio | 0.72 | 0.82 | 1.06 | 1.26 | 0.86 | 1.61 | 1.05 | 0.91 | 1.17 | 1.21 | 1.36 | 2.10 | 2.04 | 1.51 | 2.27 | 3.63 | 3.43 | 4.36 |
P/FCF Ratio | -6.33 | -5.93 | -12.14 | -13.15 | -6.96 | -13.25 | -10.03 | -9.57 | -11.74 | -10.55 | -14.21 | -32.41 | -37.23 | -18.36 | -44.97 | -67.43 | -67.53 | -83.63 |
P/OCF Ratio | -6.34 | -5.94 | -12.22 | -13.28 | -6.96 | -13.25 | -10.06 | -9.57 | -11.79 | -10.72 | -14.6 | -32.56 | -38.43 | -18.87 | -45.7 | -72.05 | -85.41 | -94.58 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | -2.54K | 1.22K | -2.52K | -2.81K | -2.22K | -1.32K | -972.55 | -494.55 | -1.12K | -890.9 | -997.51 | -935.68 | -1.29 |
Debt / Equity Ratio | 0.23 | 0.21 | 0.21 | 0.18 | 0.18 | 0.21 | 0.19 | 0.17 | 0.15 | 0.17 | 0.14 | 0.13 | 0.12 | 0.08 | 0.08 | 0.05 | 0.05 | 0.05 |
Quick Ratio | 8.92 | 9.71 | 8.54 | 9.35 | 12.25 | 12.80 | 12.43 | 12.62 | 9.20 | 8.84 | 10.85 | 11.64 | 11.69 | 13.04 | 17.22 | 9.58 | 13.18 | 13.14 |
Current Ratio | 8.92 | 9.71 | 8.54 | 9.35 | 12.25 | 12.80 | 12.38 | 12.58 | 9.18 | 8.63 | 9.70 | 11.64 | 11.42 | 12.74 | 16.80 | 9.40 | 13.09 | 13.06 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | 0.00 | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 |
Interest Coverage | 212.01 | -434.61 | -746.79 | -717.74 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.15 | -0.15 | -0.14 | -0.14 | -0.13 | -0.14 | -0.17 | -0.11 | -0.13 | -0.17 | -0.14 | -0.11 | -0.09 | -0.09 | -0.08 | -0.08 | -0.07 | -0.03 |
Return on Assets | -0.11 | -0.12 | -0.11 | -0.11 | -0.1 | -0.11 | -0.14 | -0.09 | -0.1 | -0.13 | -0.12 | -0.09 | -0.08 | -0.08 | -0.07 | -0.07 | -0.06 | -0.03 |
Return on Invested Capital | -0.13 | -0.13 | -0.12 | -0.13 | -0.11 | -0.12 | -0.14 | -0.09 | -0.11 | -0.14 | -0.13 | -0.1 | -0.08 | -0.09 | -0.07 | -0.08 | -0.07 | -0.03 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | 1.00 | 1.00 | -161.36 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | -2.95K | 2.04K | -2.83K | -3.6K | -3.33K | -2.02K | -1.7K | -869.62 | -1.31K | -1.47K | -1.6K | -1.61K | -0.86 |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | -2.95K | 2.03K | -2.83K | -3.6K | -3.33K | -2.02K | -1.7K | -869.62 | -1.31K | -1.47K | -1.6K | -1.61K | -0.86 |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | -3.16K | 1.94K | -2.86K | -3.66K | -3.3K | -2.05K | -1.68K | -890.63 | -1.31K | -1.45K | -1.59K | -1.61K | -0.87 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | -2.79K | 1.56K | -2.67K | -3.5K | -3.19K | -1.99K | -1.6K | -847.9 | -1.25K | -1.37K | -1.54K | -1.57K | -0.82 |